News

News
UC3
UC3: VitaDX, Cerballiance Finistère and the COSS laboratory are collaborating within the framework of the "Collaborative innovation at the crossroads of different sectors" initiative.
14 May 2019 -

The Characterisation of Urothelial Cancer Cells "UC3" project funded by the Brittany region, Rennes Métropole and the ERDF aims to deepen our…

La Tribune
”Paroles d’Experts” show by La Tribune
16 July 2018 -

Allan Rodriguez (CEO and co-founder of VitaDX) and Pascal Eschwège (Professor of Urology at the University Hospital of Nancy and co-founder of…

DeepTech4Good Paris
DeepTech4Good Paris
12 July 2018 -

VitaDX is very happy to be a Health & Wellness Laureate at DeepTech4Good !

Realize
REALIZE AstraZeneca
11 July 2018 -

VitaDX is very pleased to be part of the 5 Therapeutic Innovation Startups selected by AstraZeneca to be part of the support program REALIZE!

Le MAG numérique
Against cancer VitaDX invests 5 years of efforts.
31 May 2018 -

Five years of efforts to transform a patented technology into an industrialised solution, tested and certified.

Le Télégramme
Artificial intelligence. Healthcare and patients have everything to gain from the digital era – Le Télégramme
15 May 2018 -

VitaDX citée dans Le Télégramme à l'occasion de la journée Numérique & Santé.

Le MAG numérique
Data at the heart of digital health – Le Mag numérique
2 May 2018 -

VitaDX citée dans Le Mag numérique à l'occasion de la journée Numérique & Santé.

France Culture
Innovation guest in the France Culture Soft Power radio program
19 February 2018 -

Interview of Allan Rodriguez, innovation guest in the France Culture Soft Power radio program.

Les Echos
Health: The 20 best rated french startups
14 February 2018 -

VitaDX among the 20 best rated french startups.